EconomyShkreli faces contempt proceedings over pharmaceutical industry ban

The Federal Trade Commission and seven states have launched contempt proceedings against Martin Shkreli, known as “Pharma Bro.” He served nearly seven years in prison for defrauding investors.

Martin ShkreliFederal Trade Commissioncontempt proceedingspharmaceutical industry

BBloomberg News★★★☆☆2026-10-13 19:30Original